Kate Shaw, Innovative Trials' Founder & CEM, reflects on the exciting news for patients affected by cancer in the UK.
Kate Shaw, Founder & CEO of Innovative trials, welcomes the news that 29 UK experimental cancer medicine centers (ECMCs) are set to share £47.5 million over the next five years to boost trials of personalized cancer therapies.
Read more here.
Address:
Innovative Trials Ltd, Innovative House
Avenue One
Letchworth Garden City
Hertfordshire
SG6 2WW
United Kingdom